FDA Approves First Epinephrine Nasal Spray for Type I Allergic Reactions Including Anaphylaxis

Estimated read time 1 min read

Approval of neffy marks a significant advancement in epinephrine delivery, offering a less painful alternative to traditional needle injections.

You May Also Like

More From Author

+ There are no comments

Add yours